サマリー

血漿分画の世界市場 2024-2028
血漿分画市場は2023-2028年に100億米ドル成長し、予測期間中のCAGRは6.09%で加速すると予測される。当レポートでは、血漿分画市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、呼吸器疾患やAATDで治療される血漿製品の普及、血漿由来製品のリストの増加、血漿ベースの製品を製造するためのM&Aの増加によって牽引されています。
Technavioの血漿分画市場は以下のように区分される：
製品別
- 免疫グロブリン
- アルブミン
- 凝固因子濃縮物
- プロテアーゼ阻害剤
- その他
用途別
- 免疫学
- 神経学
- 血液学
- クリティカルケア
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、高齢者人口の増加と関連疾患が、今後数年間の血漿分画市場の成長を促進する主要な理由の1つであると特定している。また、血漿製品の自給率向上のための政府戦略や血漿採取の需要の高まりは、市場の大きな需要につながる。
血漿分画市場に関するレポートは以下の分野をカバーしています：
- 血漿分画市場のサイジング
- 血漿分画市場の予測
- 血漿分画市場の産業分析
本レポートでは、血漿分画市場の主要ベンダーであるADMA Biologics Inc.、Bharat Serums and Vaccines Ltd.、CSL Ltd.、Emergent BioSolutions Inc.、GC Biopharma corp.Ltd.、Grifols SA、Hemarus Plasma、Intas Pharmaceuticals Ltd.、Kamada Ltd.、Kedrion S.p.A、LFB SA、Merck KGaA、三菱化学グループ、Octapharma AG、PlasmaGen BioSciences Pvt.Ltd.、Prothya Biosolutions Netherlands BV、Sanquin、SK Inc.、武田薬品工業、Virchow Laboratories Co.Ltd.、Virchow Laboratories Ltd.。また、血漿分画市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/plasma-fractionation-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global plasma fractionation market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global plasma fractionation market 2018 - 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
o 4.3 Application Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Immunoglobulins - Market size and forecast 2023-2028
o Exhibit 34: Chart on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Immunoglobulins - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Immunoglobulins - Year-over-year growth 2023-2028 (%)
o 6.4 Albumin - Market size and forecast 2023-2028
o Exhibit 38: Chart on Albumin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Albumin - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Albumin - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Albumin - Year-over-year growth 2023-2028 (%)
o 6.5 Coagulation factor concentrates - Market size and forecast 2023-2028
o Exhibit 42: Chart on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
o 6.6 Protease inhibitors - Market size and forecast 2023-2028
o Exhibit 46: Chart on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Protease inhibitors - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Protease inhibitors - Year-over-year growth 2023-2028 (%)
o 6.7 Others - Market size and forecast 2023-2028
o Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ billion)
o Exhibit 55: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 56: Chart on Application - Market share 2023-2028 (%)
o Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 58: Chart on Comparison by Application
o Exhibit 59: Data Table on Comparison by Application
o 7.3 Immunology - Market size and forecast 2023-2028
o Exhibit 60: Chart on Immunology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Immunology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Immunology - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
o 7.4 Neurology - Market size and forecast 2023-2028
o Exhibit 64: Chart on Neurology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Neurology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Neurology - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
o 7.5 Hematology - Market size and forecast 2023-2028
o Exhibit 68: Chart on Hematology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Data Table on Hematology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 70: Chart on Hematology - Year-over-year growth 2023-2028 (%)
o Exhibit 71: Data Table on Hematology - Year-over-year growth 2023-2028 (%)
o 7.6 Critical care - Market size and forecast 2023-2028
o Exhibit 72: Chart on Critical care - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Data Table on Critical care - Market size and forecast 2023-2028 ($ billion)
o Exhibit 74: Chart on Critical care - Year-over-year growth 2023-2028 (%)
o Exhibit 75: Data Table on Critical care - Year-over-year growth 2023-2028 (%)
o 7.7 Others - Market size and forecast 2023-2028
o Exhibit 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 78: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.8 Market opportunity by Application
o Exhibit 80: Market opportunity by Application ($ billion)
o Exhibit 81: Data Table on Market opportunity by Application ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 85: Chart on Geographic comparison
o Exhibit 86: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 115: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 116: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 117: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 118: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 125: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 127: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 128: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 129: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 130: Matrix on vendor position and classification
o 12.3 ADMA Biologics Inc.
o Exhibit 131: ADMA Biologics Inc. - Overview
o Exhibit 132: ADMA Biologics Inc. - Business segments
o Exhibit 133: ADMA Biologics Inc. - Key offerings
o Exhibit 134: ADMA Biologics Inc. - Segment focus
o 12.4 Bharat Serums and Vaccines Ltd.
o Exhibit 135: Bharat Serums and Vaccines Ltd. - Overview
o Exhibit 136: Bharat Serums and Vaccines Ltd. - Product / Service
o Exhibit 137: Bharat Serums and Vaccines Ltd. - Key offerings
o 12.5 CSL Ltd.
o Exhibit 138: CSL Ltd. - Overview
o Exhibit 139: CSL Ltd. - Business segments
o Exhibit 140: CSL Ltd. - Key offerings
o Exhibit 141: CSL Ltd. - Segment focus
o 12.6 Emergent BioSolutions Inc.
o Exhibit 142: Emergent BioSolutions Inc. - Overview
o Exhibit 143: Emergent BioSolutions Inc. - Product / Service
o Exhibit 144: Emergent BioSolutions Inc. - Key news
o Exhibit 145: Emergent BioSolutions Inc. - Key offerings
o 12.7 GC Biopharma corp.
o Exhibit 146: GC Biopharma corp. - Overview
o Exhibit 147: GC Biopharma corp. - Product / Service
o Exhibit 148: GC Biopharma corp. - Key offerings
o 12.8 Grifols SA
o Exhibit 149: Grifols SA - Overview
o Exhibit 150: Grifols SA - Business segments
o Exhibit 151: Grifols SA - Key offerings
o Exhibit 152: Grifols SA - Segment focus
o 12.9 Intas Pharmaceuticals Ltd.
o Exhibit 153: Intas Pharmaceuticals Ltd. - Overview
o Exhibit 154: Intas Pharmaceuticals Ltd. - Product / Service
o Exhibit 155: Intas Pharmaceuticals Ltd. - Key offerings
o 12.10 Kedrion S.p.A
o Exhibit 156: Kedrion S.p.A - Overview
o Exhibit 157: Kedrion S.p.A - Product / Service
o Exhibit 158: Kedrion S.p.A - Key offerings
o 12.11 LFB SA
o Exhibit 159: LFB SA - Overview
o Exhibit 160: LFB SA - Product / Service
o Exhibit 161: LFB SA - Key offerings
o 12.12 Merck KGaA
o Exhibit 162: Merck KGaA - Overview
o Exhibit 163: Merck KGaA - Business segments
o Exhibit 164: Merck KGaA - Key news
o Exhibit 165: Merck KGaA - Key offerings
o Exhibit 166: Merck KGaA - Segment focus
o 12.13 Mitsubishi Chemical Group Corp.
o Exhibit 167: Mitsubishi Chemical Group Corp. - Overview
o Exhibit 168: Mitsubishi Chemical Group Corp. - Business segments
o Exhibit 169: Mitsubishi Chemical Group Corp. - Key offerings
o Exhibit 170: Mitsubishi Chemical Group Corp. - Segment focus
o 12.14 Octapharma AG
o Exhibit 171: Octapharma AG - Overview
o Exhibit 172: Octapharma AG - Product / Service
o Exhibit 173: Octapharma AG - Key offerings
o 12.15 Sanquin
o Exhibit 174: Sanquin - Overview
o Exhibit 175: Sanquin - Product / Service
o Exhibit 176: Sanquin - Key offerings
o 12.16 SK Inc.
o Exhibit 177: SK Inc. - Overview
o Exhibit 178: SK Inc. - Product / Service
o Exhibit 179: SK Inc. - Key offerings
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 180: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 181: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 182: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 184: Inclusions checklist
o Exhibit 185: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 186: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 187: Research methodology
o Exhibit 188: Validation techniques employed for market sizing
o Exhibit 189: Information sources
o 13.5 List of abbreviations
o Exhibit 190: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global plasma fractionation market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Immunoglobulins - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Immunoglobulins - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Albumin - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Albumin - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Albumin - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Protease inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Protease inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Data Table on Market opportunity by Product ($ billion)
Exhibits56: Chart on Application - Market share 2023-2028 (%)
Exhibits57: Data Table on Application - Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by Application
Exhibits59: Data Table on Comparison by Application
Exhibits60: Chart on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Immunology - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Immunology - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Neurology - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Hematology - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Hematology - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Hematology - Year-over-year growth 2023-2028 (%)
Exhibits72: Chart on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Data Table on Critical care - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Chart on Critical care - Year-over-year growth 2023-2028 (%)
Exhibits75: Data Table on Critical care - Year-over-year growth 2023-2028 (%)
Exhibits76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits79: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits80: Market opportunity by Application ($ billion)
Exhibits81: Data Table on Market opportunity by Application ($ billion)
Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits83: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits85: Chart on Geographic comparison
Exhibits86: Data Table on Geographic comparison
Exhibits87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits115: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits116: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits117: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits118: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits121: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits123: Market opportunity By Geographical Landscape ($ billion)
Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits125: Impact of drivers and challenges in 2023 and 2028
Exhibits126: Overview on Criticality of inputs and Factors of differentiation
Exhibits127: Overview on factors of disruption
Exhibits128: Impact of key risks on business
Exhibits129: Vendors covered
Exhibits130: Matrix on vendor position and classification
Exhibits131: ADMA Biologics Inc. - Overview
Exhibits132: ADMA Biologics Inc. - Business segments
Exhibits133: ADMA Biologics Inc. - Key offerings
Exhibits134: ADMA Biologics Inc. - Segment focus
Exhibits135: Bharat Serums and Vaccines Ltd. - Overview
Exhibits136: Bharat Serums and Vaccines Ltd. - Product / Service
Exhibits137: Bharat Serums and Vaccines Ltd. - Key offerings
Exhibits138: CSL Ltd. - Overview
Exhibits139: CSL Ltd. - Business segments
Exhibits140: CSL Ltd. - Key offerings
Exhibits141: CSL Ltd. - Segment focus
Exhibits142: Emergent BioSolutions Inc. - Overview
Exhibits143: Emergent BioSolutions Inc. - Product / Service
Exhibits144: Emergent BioSolutions Inc. - Key news
Exhibits145: Emergent BioSolutions Inc. - Key offerings
Exhibits146: GC Biopharma corp. - Overview
Exhibits147: GC Biopharma corp. - Product / Service
Exhibits148: GC Biopharma corp. - Key offerings
Exhibits149: Grifols SA - Overview
Exhibits150: Grifols SA - Business segments
Exhibits151: Grifols SA - Key offerings
Exhibits152: Grifols SA - Segment focus
Exhibits153: Intas Pharmaceuticals Ltd. - Overview
Exhibits154: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits155: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits156: Kedrion S.p.A - Overview
Exhibits157: Kedrion S.p.A - Product / Service
Exhibits158: Kedrion S.p.A - Key offerings
Exhibits159: LFB SA - Overview
Exhibits160: LFB SA - Product / Service
Exhibits161: LFB SA - Key offerings
Exhibits162: Merck KGaA - Overview
Exhibits163: Merck KGaA - Business segments
Exhibits164: Merck KGaA - Key news
Exhibits165: Merck KGaA - Key offerings
Exhibits166: Merck KGaA - Segment focus
Exhibits167: Mitsubishi Chemical Group Corp. - Overview
Exhibits168: Mitsubishi Chemical Group Corp. - Business segments
Exhibits169: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits170: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits171: Octapharma AG - Overview
Exhibits172: Octapharma AG - Product / Service
Exhibits173: Octapharma AG - Key offerings
Exhibits174: Sanquin - Overview
Exhibits175: Sanquin - Product / Service
Exhibits176: Sanquin - Key offerings
Exhibits177: SK Inc. - Overview
Exhibits178: SK Inc. - Product / Service
Exhibits179: SK Inc. - Key offerings
Exhibits180: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits181: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits182: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits183: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations